WO2022142518A1 - Procédé et système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire - Google Patents

Procédé et système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire Download PDF

Info

Publication number
WO2022142518A1
WO2022142518A1 PCT/CN2021/120190 CN2021120190W WO2022142518A1 WO 2022142518 A1 WO2022142518 A1 WO 2022142518A1 CN 2021120190 W CN2021120190 W CN 2021120190W WO 2022142518 A1 WO2022142518 A1 WO 2022142518A1
Authority
WO
WIPO (PCT)
Prior art keywords
pressure
state
blood vessel
hyperemia
ratio
Prior art date
Application number
PCT/CN2021/120190
Other languages
English (en)
Chinese (zh)
Inventor
邵小虎
林佳燕
Original Assignee
深圳北芯生命科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳北芯生命科技股份有限公司 filed Critical 深圳北芯生命科技股份有限公司
Publication of WO2022142518A1 publication Critical patent/WO2022142518A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852—Catheters

Definitions

  • the present application relates to the field of medical technology, and in particular, to a method and system for determining a diagnostic mode based on a vascular congestion state.
  • Fractional Flow Reserve refers to the ratio of the mean intra-coronary pressure at the distal end of the stenosis to the mean pressure at the proximal end of the coronary artery under the condition of maximum myocardial hyperemia.
  • the gold standard of blood In the process of FFR measurement, it is necessary to inject drugs to make the blood vessels reach the maximum hyperemia state, but some patients are intolerant to drugs, which leads to the limitation of FFR measurement. Based on this defect, related researchers proposed a new index for measuring intravascular pressure without drug congestion, that is, in a non-congested state, the Non-Hyperemic Pressure Ratio (NHPR).
  • NHPR Non-Hyperemic Pressure Ratio
  • the FFR index is used as the diagnostic basis in the hyperemia mode
  • the NHPR index is used as the diagnosis basis in the non-congestion mode.
  • the present application provides a method and system for determining a diagnostic mode based on a vascular congestion state, which can manually switch the diagnostic mode without manual operation, which is beneficial to saving operation time and reducing manpower.
  • a first aspect of the present application provides a method for determining a diagnostic mode based on a vascular congestion state, including:
  • the blood vessel is in a hyperemic state, calculate the first average pressure Pa' at the proximal end of the blood vessel stenosis according to the first pressure Pa in the hyperemia state, and calculate the distal end of the blood vessel stenosis according to the second pressure Pd in the hyperemia state the second mean pressure Pd' at the end, and calculate the blood flow reserve fraction according to the first mean pressure Pa' and the second mean pressure Pd';
  • the non-congested pressure ratio is calculated according to the first pressure Pa and the second pressure Pd in the non-congested state.
  • a second aspect of the present application provides a system for determining a diagnostic mode based on a vascular congestion state, including:
  • a pressure measurement device used for collecting the first pressure signal at the proximal end of the vascular stenosis, and collecting the second pressure signal at the distal end of the vascular stenosis;
  • a host computer connected to the pressure measuring device, for receiving the first pressure signal and the second pressure signal, processing the first pressure signal to obtain a first pressure Pa, and measuring the second pressure signal Perform processing to obtain a second pressure Pd; according to the first pressure Pa and/or the second pressure Pd, determine the blood vessel congestion state; if the blood vessel is in a hyperemia state, calculate the blood vessel according to the first pressure Pa in the hyperemia state The first average pressure Pa' at the proximal end of the vascular stenosis, and the second average pressure Pd' at the distal end of the vascular stenosis is calculated according to the second pressure Pd in the hyperemia state, and according to the first average pressure Pa' and The second average pressure Pd' is used to calculate the blood flow reserve fraction; if the blood vessel is in a non-congested state, the non-congested pressure ratio is calculated according to the first pressure Pa and the second pressure Pd in the non-congested state.
  • FIG. 1 is a schematic flowchart of a method for determining a diagnostic mode based on a vascular congestion state according to an embodiment of the present application
  • FIG. 2 is a pressure data waveform diagram shown in an embodiment of the present application.
  • Fig. 3 is a kind of non-congestion state and the pressure data waveform diagram under the hyperemia state shown in the embodiment of the present application;
  • FIG. 4 is a schematic structural diagram of a device for determining a diagnostic mode based on a vascular congestion state according to an embodiment of the present application
  • FIG. 5 is a schematic structural diagram of an electronic device shown in an embodiment of the present application.
  • FIG. 6 is a schematic structural diagram of a system for determining a diagnostic mode based on a vascular congestion state according to an embodiment of the present application.
  • first, second, third, etc. may be used in this application to describe various information, such information should not be limited by these terms. These terms are only used to distinguish the same type of information from each other.
  • first information may also be referred to as the second information, and similarly, the second information may also be referred to as the first information without departing from the scope of the present application.
  • second information may also be referred to as the first information without departing from the scope of the present application.
  • a feature defined as “first” or “second” may expressly or implicitly include one or more of that feature.
  • “plurality” means two or more, unless otherwise expressly and specifically defined.
  • the embodiments of the present application provide a method for determining a diagnostic mode based on a vascular congestion state. As shown in Figure 1, the method may include the following steps:
  • an interventional catheter technique can be used to measure the pressure in the blood vessel to determine the disease condition of the patient's blood vessel, such as stenosis.
  • a pressure measurement device such as a MEMS (Micro-Electro-Mechanical System, micro-electromechanical system) pressure sensor, an optical fiber pressure sensor, etc.
  • the pressure measurement device may include a first pressure sensor and a second pressure sensor, wherein the first pressure sensor may be arranged outside the human body, and by being connected with the guiding catheter (hollow) inserted into the human body, the blood drawn from the guiding catheter can be sensed pressure.
  • the head end of the guiding catheter is located at the proximal end of the vascular stenosis lesion, and the tail end is arranged outside the body and is connected with the first pressure sensor, so that the first pressure sensor can measure the pressure data of the proximal end of the vascular stenosis lesion.
  • the second pressure sensor can be installed in the human body, and can be integrated at the head end of the pressure micro-catheter. The pressure micro-catheter passes through the guide catheter and penetrates deep into the distal end of the vascular stenosis, so that the second pressure sensor can measure the distal end of the vascular stenosis. pressure data.
  • the first pressure sensor and the second pressure sensor may be respectively subjected to a zero calibration process. Afterwards, pressure equalization can be performed on the two pressure sensors. In one embodiment, when the second pressure sensor reaches the head end of the guiding catheter, the second pressure sensor is adjusted based on the pressure of the first pressure sensor, so that the two pressure sensors are adjusted. The pressure sensor maintains a unified pressure reference, so that the measurement error between the two pressure sensors can be eliminated, thereby improving the accuracy of the measurement results.
  • the blood vessel may be a coronary artery
  • the proximal end of the vascular stenosis lesion may be the coronary ostium
  • the distal end of the vascular stenosis lesion may be the distal end of the coronary stenosis lesion and away from the coronary ostium.
  • other blood vessels such as peripheral blood vessels
  • the first pressure sensor may be used to collect the pressure data of the proximal end of the vascular stenosis in real time
  • the second pressure sensor may be used to collect the pressure data of the distal end of the vascular stenosis in real time, respectively through analog-to-digital conversion (analog data collected by the pressure sensor).
  • the signal is converted into a digital electrical signal
  • the pressure calculation (the digital electrical signal is converted into a pressure value), and finally converted into a first pressure Pa and a second pressure Pd.
  • the first pressure Pa and the second pressure Pd may also be obtained directly from a local storage device or a network terminal.
  • the first pressure Pa obtained by converting the pressure data collected by the first pressure sensor can be stored in a data link list, where the data link list uses time as an index, and takes time and real-time pressure values as key-value pairs. save.
  • the second pressure Pd obtained by converting the pressure data collected by the second pressure sensor may be stored in the above method.
  • the data link list can be stored in local storage or on the network. Taking the time as the index value, the corresponding pressure value is obtained from the data link table to obtain the first pressure Pa and the second pressure Pd.
  • the first pressure Pa at different times can generate a pressure waveform curve
  • the second pressure Pd at the same time can also generate a pressure waveform curve.
  • Figure 2 contains two sets of waveform diagrams, the previous group of waveform diagrams is the waveform curve of the first pressure Pa, the waveform curve of the second pressure Pd, and the average value of the first pressure Pa at different times.
  • the fourth average pressure obtained by summing and averaging the second pressure Pd at different times the abscissa represents time, in seconds; the ordinate represents pressure, in millimeters of mercury.
  • the upper waveform in the next set of waveforms represents the real-time pressure difference between the first pressure Pa and the second pressure Pd
  • the lower waveform represents the fourth average pressure with the third mean pressure ratio.
  • Figure 2 is the corresponding waveform in the maximum hyperemia state
  • the fourth average pressure with the third mean pressure The ratio is the FFR value.
  • the waveforms of the first pressure Pa and the second pressure Pd are basically the same. Therefore, it can be determined whether the blood vessel is not based on the waveform of the first pressure Pa and/or the waveform of the second pressure Pd. in a state of maximum hyperemia.
  • a specific embodiment of determining the blood vessel congestion state according to the first pressure Pa and/or the second pressure Pd in step S120 may include the following steps:
  • the first pressure Pa measured in real time by the first pressure sensor can be used to sum and average to obtain the third average pressure
  • the second pressure Pd measured in real time by the second pressure sensor is summed and averaged to obtain the fourth average pressure
  • the fourth average pressure with the third mean pressure The change of the ratio to identify whether the blood vessels are congested or not.
  • the fourth average pressure with the third mean pressure After a period of time stability (stage 1: stable period without hyperemia) and then an overall decrease (stage 2: fluctuating period under hyperemia), the ratio begins to decrease and it can be considered that the injection of drugs (such as adenosine) is started to make the blood vessels reach the Maximum hyperemia.
  • drugs such as adenosine
  • the hyperemia state enters a stable period (stage 3: the stable period in the hyperemia state), and when the drug injection is stopped, the mean pressure ratio begins to rise again (stage 4: the transition from the hyperemia state to the non-congestive state).
  • stage 3 the stable period in the hyperemia state
  • stage 4 the transition from the hyperemia state to the non-congestive state.
  • a specific embodiment of determining the blood vessel congestion state according to the first pressure Pa and/or the second pressure Pd in step S120 may include the following steps:
  • the sample model can be used for multiple sets of historical pressure data in a non-congested state and a hyperemic state through deep learning algorithm training;
  • the vascular congestion state is determined.
  • multiple sets of historical pressure data can be manually calibrated and divided into two states: hyperemia and non-congestion, and then trained and fitted by a multi-layer neural network to acquire The characteristic difference between congested and uncongested waveforms is used to obtain a sample model.
  • the waveforms of the first pressure Pa and/or the second pressure Pd as input data into the sample model obtained by training for prediction and comparison, the judgment of the congestion and non-congestion states is completed, and the recognition of the blood vessel congestion state is realized.
  • one of the above two methods can be used to intelligently identify the vascular congestion state, and the two methods can also be combined to intelligently identify, which is not limited here.
  • the first average pressure Pa' at the proximal end of the vascular stenosis can be obtained by summing the first pressure Pa' within a period of time (such as stage 3) after the congestive state is stable, and taking the second pressure Pd within the same time period to obtain the mean value. and take the average to obtain the second mean pressure Pd' at the distal end of the vessel stenosis. By calculating the ratio of the second mean pressure Pd' to the first mean pressure Pa', the fractional flow reserve FFR value is obtained.
  • step S130 calculates the first average pressure Pa' at the proximal end of the vascular stenosis according to the first pressure Pa in the hyperemia state, and calculates the first average pressure Pa' at the distal end of the vascular stenosis according to the second pressure Pd under the hyperemia state.
  • Specific embodiments of the two average pressures Pd' may include:
  • the second average pressure Pd' at the distal end of the vascular stenosis is calculated according to the second pressure Pd of the at least one cardiac cycle in the hyperemia state.
  • the mean pressure in order to make the value of the mean pressure more accurate, may be calculated by using the pressure value of at least one cardiac cycle. Because not only the pressure value will change before and after vascular congestion, but also the cardiac cycle may change. For example, the cardiac cycle after hyperemia is smaller than the cardiac cycle before hyperemia.
  • a specific embodiment of calculating the non-congestive pressure ratio according to the first pressure Pa and the second pressure Pd in the non-congestive state may include the following steps:
  • the cardiac cycle consists of systole and diastole, with pressure increasing during systole and decreasing during diastole.
  • the first pressure Pa and the second pressure Pd in a period of time during the diastolic period of at least one cardiac cycle in a non-congestive state can be taken. In one embodiment, the time from 25% of the beginning of the diastolic period to 5 ms before the end of the diastolic period can be taken.
  • the no-congestion pressure ratio NHPR value can be obtained by calculating the ratio of the second pressure Pd to the first pressure Pa in the no-wave period and taking the average value.
  • the stationary period in each cardiac cycle may also be calculated, wherein the stationary period may be a period of time during which the ratio of the second pressure Pd and the first pressure Pa is derived in time, and the derivative is stable and tends to 0.
  • the stationary phase is also in the diastolic phase of the cardiac cycle.
  • the NHPR value can be obtained by taking the ratio of the second pressure Pd to the first pressure Pa in the stationary phase in at least one cardiac cycle, and then taking the average value.
  • the method shown in FIG. 1 may further comprise the following steps:
  • the non-congestive pressure ratio is displayed.
  • the FFR diagnostic mode when the blood vessel is in a congested state, the FFR diagnostic mode can be entered, and after the FFR value is calculated, the FFR value can be output and displayed, so that relevant personnel (such as researchers, doctors, etc.) can use the FFR value as the The diagnosis is based on the determination of the myocardial ischemia of the patient, and then the treatment plan is determined. For example, if the FFR value is less than 0.75, manual intervention can be performed for revascularization, such as stent placement; if the FFR value is greater than 0.8, conservative drug therapy can be performed.
  • the NHPR diagnostic mode can be entered. After the NHPR value is calculated, the NHPR value can be output and displayed, so that the relevant personnel can use the NHPR value as a diagnostic basis to determine the patient's myocardial ischemia. Determine a treatment plan. For example, if the NHPR value is less than 0.9, manual intervention treatment can be performed; if the NHPR value is greater than 0.9, drug conservative treatment can be performed.
  • the specific embodiment of displaying the fractional blood flow reserve may further include the following steps:
  • the grayscale interval of the FFR value is generally set to be between 0.75 and 0.8.
  • the diagnosis scheme can be determined in combination with the NHPR value.
  • the NHPR value before hyperemia can be obtained and displayed in dual mode, that is, the FFR value and the NHPR value can be displayed at the same time, so that the NHPR value can be used as auxiliary diagnostic information, which can better allow relevant personnel to draw treatment plans. For example, if the FFR value is between 0.75 and 0.8 and the NHPR value is less than 0.9, manual intervention treatment can be performed; if the FFR value is between 0.75 and 0.8 and the NHPR value is greater than 0.9, conservative drug treatment can be performed. It can be understood that, the NHPR value calculated within a period of time after the congestion is over (for example, after stopping the injection of adenosine) can also be obtained as auxiliary diagnostic information, which is not limited here.
  • the specific embodiment of displaying the non-congestive pressure ratio may further include the following steps:
  • the diagnostic information can be comprehensively output in combination with the FFR value in the hyperemic state. For example, assuming that the critical interval of the NHPR value is 0.86-0.93, when the NHPR value is between 0.86-0.93 and the FFR value is less than 0.75, manual intervention can be performed; when the NHPR value is between 0.86-0.93 and the FFR value is greater than 0.8, Conservative drug treatment is possible.
  • the embodiments of the present application identify the vascular congestion state by analyzing the fluctuation of the first pressure Pa at the proximal end of the vascular stenosis and/or the fluctuation of the second pressure Pd at the distal end of the vascular stenosis; Calculate the ratio of the first average pressure Pa' at the proximal end of the vascular stenosis to the second average pressure Pd' at the distal end of the vascular stenosis in the hyperemic state, and obtain the fractional flow reserve FFR value;
  • the non-congestion pressure ratio NHPR value is obtained by calculating the first pressure Pa and the second pressure Pd in the state.
  • the present application can intelligently identify the vascular congestion state by analyzing the vascular pressure data, and automatically switch to the corresponding mode to calculate the diagnostic parameters according to the identification result, without manual manual operation. , which can help save operation time and reduce manpower.
  • the present application also supports dual-mode display. For the critical area of FFR diagnosis and the critical area of NHPR diagnosis, auxiliary diagnosis information can be comprehensively output, which can better guide doctors to determine the treatment plan.
  • the embodiments of the present application further provide a device for determining a diagnostic mode based on a vascular congestion state, which can be used to execute the method for determining a diagnostic mode based on a vascular congestion state provided in the foregoing embodiments.
  • the apparatus may include:
  • a pressure acquisition module 41 configured to acquire the first pressure Pa at the proximal end of the vascular stenosis and the second pressure Pd at the distal end of the vascular stenosis;
  • a state determination module 42 configured to determine the vascular congestion state according to the first pressure Pa and/or the second pressure Pd;
  • the first calculation module 43 is configured to calculate the first average pressure Pa' at the proximal end of the vascular stenosis according to the first pressure Pa in the hyperemia state when the state determination module 42 determines that the blood vessel is in a hyperemia state, and calculate the first average pressure Pa' at the proximal end of the vascular stenosis according to the first pressure Pa in the hyperemia state,
  • the pressure Pd calculates the second mean pressure Pd' at the distal end of the vascular stenosis, and calculates the blood flow reserve fraction according to the first mean pressure Pa' and the second mean pressure Pd';
  • the second calculation unit 44 is configured to calculate the non-congestive pressure ratio according to the first pressure Pa and the second pressure Pd in the non-congested state when the state determination module 42 determines that the blood vessel is in the non-congested state.
  • the first calculation module 43 calculates the first average pressure Pa′ at the proximal end of the vascular stenosis according to the first pressure Pa in the hyperemia state, and calculates the second average pressure at the distal end of the vascular stenosis according to the second pressure Pd under the hyperemia state.
  • the way of pressing Pd' can include:
  • the first calculation module 43 determines the cardiac cycle in the hyperemia state according to the fluctuation law of the first pressure Pa and/or the second pressure Pd in the hyperemia state, and according to the first pressure of at least one cardiac cycle in the hyperemia state Pa calculates the first average pressure Pa' at the proximal end of the vascular stenosis, and calculates the second average pressure Pd' at the distal end of the vascular stenosis according to the second pressure Pd in the at least one cardiac cycle in the hyperemia state.
  • the second calculation unit 44 may be specifically configured to determine the cardiac cycle in the non-congestive state according to the fluctuation law of the first pressure Pa and/or the fluctuation law of the second pressure Pd in the non-congestive state, and calculate the non-congestive state.
  • the ratio of the second pressure Pd in the diastolic phase to the first pressure Pa in the next at least one cardiac cycle is obtained to obtain the non-congestive pressure ratio.
  • the apparatus shown in FIG. 4 may further include a first display module and a second display module (not shown in the figure), in one embodiment:
  • the first display module is used to display the blood flow reserve fraction when the blood vessel is in a congested state
  • the second display module is used for displaying the no-congestion pressure ratio when the blood vessel is in the no-congestion state.
  • the first display module may display the blood flow reserve fraction in a manner including:
  • the first display module acquires the non-congestion pressure ratio before the hyperemia state when the blood flow reserve fraction is within the preset grayscale interval; and simultaneously displays the blood flow reserve fraction and the non-congestion pressure ratio before the hyperemia state.
  • the second display module may display the non-congestive pressure ratio in a manner including:
  • the second display module obtains the blood flow reserve fraction under the hyperemia state when the non-congestive pressure ratio is within the preset critical interval; and simultaneously displays the non-congestive pressure ratio and the blood flow reserve fraction under the hyperemia state.
  • the state determination module 42 may be specifically configured to calculate the third average pressure at the proximal end of the vascular stenosis according to the first pressure Pa. Calculate the fourth mean pressure at the distal end of the vessel stenosis based on the second pressure Pd According to the fourth mean pressure with the third mean pressure Changes in the ratio to determine the state of vascular congestion.
  • the state determination module 42 may be specifically configured to use the first pressure Pa and/or the second pressure Pd as input data, input the sample model for prediction, obtain the prediction result, and determine the vascular congestion state according to the prediction result;
  • the sample model is trained by deep learning algorithm using multiple sets of historical pressure data in non-congested and hyperemic states.
  • Implementing the device shown in Figure 4 can intelligently identify the vascular congestion state by analyzing the vascular pressure data, and automatically switch to the corresponding mode to calculate the diagnostic parameters according to the identification result, without manual manual operation. When applied in clinical practice, it can help save surgery. time and reduce manpower.
  • the device also supports dual-mode display, and can comprehensively output auxiliary diagnosis information for the critical area of FFR diagnosis and the critical area of NHPR diagnosis, which can better guide doctors to determine the treatment plan.
  • Embodiments of the present application further provide an electronic device, which can be used to execute the method for determining a diagnostic mode based on a vascular congestion state provided by the foregoing embodiments.
  • the electronic device 500 may include: at least one processor 501 , memory 502 , at least one communication interface 503 and other components. Among other things, these components may be communicatively connected through one or more communication buses 504 .
  • the structure of the electronic device 500 shown in FIG. 5 does not constitute a limitation on the embodiments of the present application, and it may be a bus-shaped structure or a star-shaped structure, and may also include more More or fewer components, or a combination of certain components, or a different arrangement of components. in:
  • the processor 501 may be a central processing unit (Central Processing Unit, CPU), or other general-purpose processors, digital signal processors (Digital Signal Processors, DSPs), application specific integrated circuits (Application Specific Integrated Circuits, ASICs), field-available processors. Field-Programmable Gate Array (FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc.
  • a general purpose processor may be a microprocessor or the processor may be any conventional processor or the like.
  • Memory 502 may include various types of storage units, such as system memory, read only memory (ROM), and persistent storage.
  • the ROM may store static data or instructions required by the processor 501 or other modules of the computer.
  • Persistent storage devices may be readable and writable storage devices.
  • Permanent storage may be a non-volatile storage device that does not lose stored instructions and data even if the computer is powered off.
  • persistent storage devices employ mass storage devices (eg, magnetic or optical disks, flash memory) as persistent storage devices.
  • persistent storage may be a removable storage device (eg, a floppy disk, an optical drive).
  • System memory can be a readable and writable storage device or a volatile readable and writable storage device, such as dynamic random access memory.
  • System memory can store some or all of the instructions and data that the processor needs at runtime.
  • memory 502 may comprise any combination of computer-readable storage media, including various types of semiconductor memory chips (DRAM, SRAM, SDRAM, flash memory, programmable read only memory), magnetic and/or optical disks may also be employed.
  • the memory 502 may include a removable storage device that is readable and/or writable, such as a compact disc (CD), a read-only digital versatile disc (eg, DVD-ROM, dual-layer DVD-ROM), Read-only Blu-ray Discs, Ultra-Density Discs, Flash Cards (eg SD Cards, Min SD Cards, Micro-SD Cards, etc.), Magnetic Floppy Disks, etc.
  • a removable storage device that is readable and/or writable, such as a compact disc (CD), a read-only digital versatile disc (eg, DVD-ROM, dual-layer DVD-ROM), Read-only Blu-ray Discs, Ultra-Density Discs, Flash Cards (eg SD Cards, Min SD Cards, Micro-SD Cards, etc.), Magnetic Floppy Disks, etc.
  • Computer readable storage media do not contain carrier waves and transient electronic signals transmitted over wireless or wire.
  • the communication interface 503 may include a wired communication interface, a wireless communication interface, etc., and may be used to communicate and interact with pressure sensors or other devices.
  • the memory 502 stores executable codes, and when the executable codes are processed by the processor 501, the processor 501 can be made to execute some or all of the steps in the above-mentioned method for determining a diagnostic mode based on a blood vessel congestion state.
  • the embodiments of the present application further provide a system for determining a diagnostic mode based on a vascular congestion state, which can be used to execute the method for determining a diagnostic mode based on a vascular congestion state provided in the foregoing embodiments.
  • the system may at least include: a pressure measuring device 10 and a host 20, wherein:
  • the pressure measurement device 10 is used for collecting the first pressure signal at the proximal end of the vascular stenosis, and collecting the second pressure signal at the distal end of the vascular stenosis;
  • the host 20, connected with the pressure measuring device 10, is used for receiving the first pressure signal and the second pressure signal, processing the first pressure signal to obtain the first pressure Pa, and processing the second pressure signal to obtain the second pressure Pd;
  • the blood vessel congestion state is determined; if the blood vessel is in the hyperemia state, the first average pressure Pa' at the proximal end of the blood vessel stenosis is calculated according to the first pressure Pa in the hyperemia state, and Calculate the second average pressure Pd' at the distal end of the vascular stenosis, and calculate the blood flow reserve fraction according to the first average pressure Pa' and the second average pressure Pd'; if the blood vessel is in a non-congested state, according to the The no-congestion pressure ratio is calculated from the first pressure Pa and the second pressure Pd in the state.
  • the host computer 20 may include a lower computer 21 and an upper computer 22, and the lower computer 21 is connected with the upper computer 22, wherein:
  • the lower computer 21 is used for receiving the first pressure signal and the second pressure signal, processing the first pressure signal to obtain the first pressure Pa, and processing the second pressure signal to obtain the second pressure Pd, and combining the first pressure Pa and the second pressure signal.
  • the second pressure Pd is sent to the upper computer 22;
  • the upper computer 22 is used to determine the blood vessel congestion state according to the first pressure Pa and/or the second pressure Pd; if the blood vessel is in the blood vessel state, calculate the first average pressure Pa' of the proximal end of the blood vessel stenosis according to the first pressure Pa under the blood vessel state , and calculate the second average pressure Pd' at the distal end of the vascular stenosis according to the second pressure Pd in the hyperemia state, and calculate the blood flow reserve fraction according to the first average pressure Pa' and the second average pressure Pd'; state, the non-congestive pressure ratio is calculated according to the first pressure Pa and the second pressure Pd in the non-congested state.
  • the manner in which the host computer 22 determines the blood vessel congestion state according to the first pressure Pa and/or the second pressure Pd may include:
  • the upper computer 22 calculates the third average pressure at the proximal end of the vascular stenosis according to the first pressure Pa Calculate the fourth mean pressure at the distal end of the vessel stenosis based on the second pressure Pd According to the fourth mean pressure with the third mean pressure Changes in the ratio to determine the state of vascular congestion.
  • the manner in which the host computer 22 determines the blood vessel congestion state according to the first pressure Pa and/or the second pressure Pd may include:
  • the host computer 22 takes the first pressure Pa and/or the second pressure Pd as input data, inputs the sample model for prediction, obtains the prediction result, and determines the vascular congestion state according to the prediction result; wherein, the sample model uses the non-congestive state and the hyperemia state.
  • the multiple sets of historical pressure data in the state are obtained through deep learning algorithm training.
  • the host computer 22 calculates the first average pressure Pa' at the proximal end of the vascular stenosis according to the first pressure Pa in the hyperemia state, and calculates the second average pressure Pd at the distal end of the vascular stenosis according to the second pressure Pd under the hyperemia state.
  • ' way can include:
  • the host computer 22 determines the cardiac cycle under the hyperemia state according to the fluctuation law of the first pressure Pa and/or the second pressure Pd under the hyperemia state; calculates the blood vessel according to the first pressure Pa of at least one cardiac cycle under the hyperemia state.
  • the first mean pressure Pa' at the proximal end of the stenosis; the second mean pressure Pd' at the distal end of the vessel stenosis is calculated according to the second pressure Pd at the at least one cardiac cycle in the hyperemia state.
  • the manner in which the host computer 22 calculates the non-congestive pressure ratio according to the first pressure Pa and the second pressure Pd in the non-congested state may include:
  • the host computer 22 determines the cardiac cycle in the non-congested state according to the fluctuation law of the first pressure Pa and/or the fluctuation law of the second pressure Pd in the non-congested state; The ratio of the second pressure Pd to the first pressure Pa to obtain the no-congestion pressure ratio.
  • the lower computer 21 may include an analog-to-digital conversion module, a pressure conversion module, and a first communication module.
  • the analog-to-digital conversion module is used to convert the first pressure signal and the second pressure signal from analog signals into digital electrical signals.
  • the pressure conversion module is used to convert the digital electrical signal converted by the analog-to-digital conversion module into a corresponding pressure value, thereby obtaining the first pressure Pa and the second pressure Pd.
  • the first pressure Pa and the second pressure Pd are then sent to the upper computer 22 through the first communication module.
  • the upper computer 22 may include a second communication module, a storage module and a processing module.
  • the second communication module is connected with the first communication module, and is used for receiving the first pressure Pa and the second pressure Pd.
  • the storage module is used to store the first pressure Pa, the second pressure Pd, and other data.
  • the processing module is used to determine the vascular congestion state according to the first pressure Pa and/or the second pressure Pd, calculate the blood flow reserve fraction in the hyperemia state, and calculate the non-congestion pressure ratio in the non-congestive state.
  • the host computer 22 can also be used to display the blood flow reserve fraction when the blood vessel is in a congested state; and display the non-congestive pressure ratio when the blood vessel is in a non-congested state.
  • the upper computer 22 may display the blood flow reserve fraction in the following manner:
  • the host computer 22 obtains the non-congestive pressure ratio before the hyperemia state, and simultaneously displays the blood flow reserve fraction and the non-congestive pressure ratio before the hyperemia state.
  • the upper computer 22 displays the non-congestive pressure ratio in a manner including:
  • the host computer 22 obtains the blood flow reserve fraction in the hyperemia state when the non-congestion pressure ratio is within the preset critical interval, and simultaneously displays the non-congestion pressure ratio and the blood flow reserve fraction in the hyperemia state.
  • the host computer 22 may further include a display module, which may be used to display different diagnostic parameters in different modes, and may also support dual-mode display, that is, simultaneously display the FFR value and the NHPR value.
  • the display module can also be used to display real-time waveforms of the first pressure Pa, the second pressure Pd, and Pd/Pa.
  • the pressure measurement device 10 may include a first pressure sensor 11 and a second pressure sensor 12, and both the first pressure sensor 11 and the second pressure sensor 12 are connected to the host 20; wherein:
  • the first pressure sensor 11 is used to collect the first pressure signal of the proximal end of the vascular stenosis and send it to the host 20;
  • the second pressure sensor 12 is used to collect the second pressure signal at the distal end of the stenosis of the blood vessel, and send it to the host 20 .
  • Implementing the system shown in FIG. 6 can intelligently identify the state of vascular congestion, display different diagnostic parameters in different states, and no manual operation is required. When applied in clinical practice, it can save operation time and reduce manpower.
  • the system can also support dual-mode operation of FFR and NHPR. FFR and NHPR can be used as complementary diagnostic results. When the FFR is in the critical range, the NHPR value can be referred to, which can guide intraoperative operations more accurately.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

La présente invention concerne un procédé et un système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire. Le procédé consiste à : obtenir une première pression Pa d'une extrémité proximale de sténose vasculaire et une deuxième pression Pd d'une extrémité distale de sténose vasculaire ; déterminer un état d'hyperémie vasculaire en fonction de la première pression Pa et/ou de la deuxième pression Pd ; si un vaisseau sanguin est dans l'état d'hyperémie, calculer une première pression moyenne Pa' de l'extrémité proximale de la sténose vasculaire en fonction de la première pression Pa dans l'état d'hyperémie, calculer une deuxième pression moyenne Pd' de l'extrémité distale de la sténose vasculaire selon la deuxième pression Pd dans l'état d'hyperémie et calculer une réserve d'écoulement fractionnaire en fonction de la première pression moyenne Pa' et de la deuxième pression moyenne Pd' ; et si le vaisseau sanguin est dans un état de non-hyperémie, calculer un rapport de pression non hyperémique en fonction de la première pression Pa et de la deuxième pression Pd dans l'état de non-hyperémie. Selon la solution apportée par les modes de réalisation de la présente invention, la commutation manuelle d'un mode de diagnostic n'est pas nécessaire, une durée de fonctionnement est économisée et la main d'œuvre est réduite.
PCT/CN2021/120190 2020-12-28 2021-09-24 Procédé et système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire WO2022142518A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011581408.4A CN112617771B (zh) 2020-12-28 2020-12-28 基于血管充血状态的诊断模式确定方法及系统
CN202011581408.4 2020-12-28

Publications (1)

Publication Number Publication Date
WO2022142518A1 true WO2022142518A1 (fr) 2022-07-07

Family

ID=75325647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/120190 WO2022142518A1 (fr) 2020-12-28 2021-09-24 Procédé et système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire

Country Status (2)

Country Link
CN (3) CN113940651B (fr)
WO (1) WO2022142518A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113940651B (zh) * 2020-12-28 2022-06-21 深圳北芯生命科技股份有限公司 基于血管充血状态的诊断模式确定方法及系统
CN113827198A (zh) * 2021-10-28 2021-12-24 深圳北芯生命科技股份有限公司 脉管内参数测量系统

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032886A1 (en) * 1999-03-09 2003-02-13 Elhanan Dgany System for determining coronary flow reserve (CFR) value for a stenosed blood vessel, CFR processor therefor, and method therefor
CN105636509A (zh) * 2013-10-18 2016-06-01 火山公司 用于利用在不使用充血剂的情况下获得的优化的近端压力测量结果和远端压力测量结果来评估脉管的设备、系统和方法
CN106456026A (zh) * 2014-04-04 2017-02-22 圣犹达医疗系统公司 血管内压力和流量数据诊断系统、设备和方法
CN107148239A (zh) * 2014-09-11 2017-09-08 皇家飞利浦有限公司 用于脉管评估的床边控制器和相关联的装置、系统和方法
US20190167188A1 (en) * 2016-08-11 2019-06-06 Foundry Innovation & Research 1, Ltd. Systems and Methods for Patient Fluid Management
CN112617771A (zh) * 2020-12-28 2021-04-09 深圳北芯生命科技有限公司 基于血管充血状态的诊断模式确定方法及系统

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221667A (en) * 1990-01-22 1993-06-22 Warner-Lambert Company Renin inhibiting peptides having an α-heteroatom amino acid at the P3 position
EP1251769A1 (fr) * 1999-03-09 2002-10-30 Florence Medical Ltd. Procede et systeme pour effectuer des mesures, basees sur la pression, de la reserve coronarienne et d'autres parametres hemodynamiques cliniques
US9220437B2 (en) * 2010-05-14 2015-12-29 Centre For Development Of Advanced Computing Diagnostic classifications of pulse signal waveform data
US8315812B2 (en) * 2010-08-12 2012-11-20 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
CN108294735B (zh) * 2012-03-13 2021-09-07 西门子公司 用于冠状动脉狭窄的非侵入性功能评估的方法和系统
US9943233B2 (en) * 2012-10-24 2018-04-17 Cathworks Ltd. Automated measurement system and method for coronary artery disease scoring
US9042613B2 (en) * 2013-03-01 2015-05-26 Heartflow, Inc. Method and system for determining treatments by modifying patient-specific geometrical models
CN105431135A (zh) * 2013-11-08 2016-03-23 泰尔克斯公司 用于治疗手术并发症的聚合给药系统
CN103793593B (zh) * 2013-11-15 2018-02-13 吴一兵 一种获取大脑状态客观定量指标的方法
JP6422653B2 (ja) * 2014-01-24 2018-11-14 日本光電工業株式会社 モニタリング装置
CN103932694A (zh) * 2014-05-07 2014-07-23 霍云龙 精确诊断心肌血流储备分数（ffr）的方法和设备
US10849511B2 (en) * 2014-07-14 2020-12-01 Philips Image Guided Therapy Corporation Devices, systems, and methods for assessment of vessels
UA99363U (uk) * 2015-01-26 2015-05-25 Марина Миколаївна Кочуєва Спосіб визначення функціонального стану ендотелію
EP3456243A1 (fr) * 2017-09-14 2019-03-20 Koninklijke Philips N.V. Géométrie de récipients améliorée et conditions limites supplémentaires pour simulations ifr/ffr hémodynamiques d'imagerie intravasculaire
EP3488774A1 (fr) * 2017-11-23 2019-05-29 Koninklijke Philips N.V. Guide de mesure pour l'estimation du débit coronaire selon le principe de bernoulli
CN209357045U (zh) * 2017-12-30 2019-09-06 深圳北芯生命科技有限公司 Ffr主机的数据恢复系统
CN110226923B (zh) * 2018-03-05 2021-12-14 苏州润迈德医疗科技有限公司 一种无需血管扩张剂测量血流储备分数的方法
WO2020028726A1 (fr) * 2018-08-01 2020-02-06 Idx Technologies, Inc. Diagnostic autonome d'affections auriculaires à partir de données de biomarqueurs
CN110731771A (zh) * 2019-10-17 2020-01-31 北京工业大学 一种无创计算个性化冠状动脉分支血流储备能力的方法
CN110916640B (zh) * 2019-11-06 2023-04-14 唯智医疗科技(佛山)有限公司 基于ffr的冠状动脉狭窄功能性缺血的检测方法及装置
CN111466900B (zh) * 2020-05-08 2021-09-21 深圳北芯生命科技股份有限公司 使用血压来跟踪心脏循环事件的系统及方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032886A1 (en) * 1999-03-09 2003-02-13 Elhanan Dgany System for determining coronary flow reserve (CFR) value for a stenosed blood vessel, CFR processor therefor, and method therefor
CN105636509A (zh) * 2013-10-18 2016-06-01 火山公司 用于利用在不使用充血剂的情况下获得的优化的近端压力测量结果和远端压力测量结果来评估脉管的设备、系统和方法
CN106456026A (zh) * 2014-04-04 2017-02-22 圣犹达医疗系统公司 血管内压力和流量数据诊断系统、设备和方法
CN107148239A (zh) * 2014-09-11 2017-09-08 皇家飞利浦有限公司 用于脉管评估的床边控制器和相关联的装置、系统和方法
US20190167188A1 (en) * 2016-08-11 2019-06-06 Foundry Innovation & Research 1, Ltd. Systems and Methods for Patient Fluid Management
CN112617771A (zh) * 2020-12-28 2021-04-09 深圳北芯生命科技有限公司 基于血管充血状态的诊断模式确定方法及系统

Also Published As

Publication number Publication date
CN113951842A (zh) 2022-01-21
CN112617771A (zh) 2021-04-09
CN112617771B (zh) 2021-11-09
CN113951842B (zh) 2022-04-29
CN113940651A (zh) 2022-01-18
CN113940651B (zh) 2022-06-21

Similar Documents

Publication Publication Date Title
US20210361176A1 (en) Method for calculating instantaneous wave-free ratio based on pressure sensor and angiogram images
WO2022142518A1 (fr) Procédé et système de détermination de mode de diagnostic basé sur l'état d'hyperémie vasculaire
WO2020007041A1 (fr) Appareil et procédé de mesure de la pression artérielle, dispositif électronique et support de stockage lisible par ordinateur
US11779233B2 (en) Method for calculating fractional flow reserve based on pressure sensor and angiographic image
US8771197B2 (en) Detection of parameters in cardiac output related waveforms
CN104116503B (zh) 一种无创连续血压的测量装置
US20130085357A1 (en) Haemodynamic monitoring device
WO2017092020A1 (fr) Procédé et appareil de mesure de la pression artérielle
WO2020098705A1 (fr) Procédé et dispositif d'obtention de paramètres d'évaluation vasculaire à l'état de repos sur la base d'image angiographique
WO2022237161A1 (fr) Procédé de mesure d'intensité d'onde et de puissance d'onde d'artère cérébrale, équipement terminal et support de stockage
WO2019242160A1 (fr) Procédé et dispositif d'obtention d'une valeur de tension artérielle sur la base de paramètres physiologiques spécifiques
WO2021031355A1 (fr) Procédé et appareil de mesure de tension et de rapport dans une période sans onde et système et support d'enregistrement
Padwal et al. Accuracy of oscillometric blood pressure algorithms in healthy adults and in adults with cardiovascular risk factors
JP2022554297A (ja) 生理パラメータに基づき血管評定パラメータを取得する方法、装置及び記憶媒体
Parati et al. How to assess arterial compliance in humans
US20150157217A1 (en) Analysis System for Cardiac Information and Analyzing Method Thereof
CN105310678B (zh) 一种基于脉波分析法计算心脏每搏血量的检测方法
CN114376546B (zh) 一种支持双诊断模式的系统
KR20080030189A (ko) 혈관의 건강 상태를 감시하는 방법 및 장치
CN113712524B (zh) 一种用于辅助评估心血管风险的数据处理装置、系统及试剂盒
EP4173555A1 (fr) Dispositif, système et procédé d'étalonnage d'un substitut de pression sanguine à utiliser dans la surveillance de la pression sanguine d'un sujet
JP7175304B2 (ja) シャント音解析装置及び方法、コンピュータプログラム並びに記憶媒体
CN114587309B (zh) 一种血压测量方法及系统
WO2018236252A1 (fr) Méthode d'évaluation du risque de complications du système cardiovasculaire avec une pathologie concomitante
Weber et al. Pulsatile and steady‐state 24‐hour hemodynamics in adolescents and young adults: the next steps ahead

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21913263

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21913263

Country of ref document: EP

Kind code of ref document: A1